Showing results (241-250 of 5,925) with videos related to
Sort By:
Pageof 593
The Prostate|September 25, 2004
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPHRosebud O Roberts, Erik J Bergstralh, Sara A Farmer, et al.The Prostate|September 25, 2004
Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell linesMurielle Mimeault, Nathalie Jouy, Patrick Depreux, et al.The Prostate|September 25, 2004
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyChuanliang Xu, Monika Jung, Mick Burkhardt, et al.The Prostate|September 25, 2004
Association of HER-2 polymorphism with Japanese sporadic prostate cancer susceptibilityAkira Yokomizo, Hirofumi Koga, Naoko Kinukawa, et al.The Prostate|September 25, 2004
Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluationAnja Michael, Carsten Stephan, Glen Kristiansen, et al.The Prostate|September 25, 2004
Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferationShinji Sakamoto, Masahiro Yokoyama, Michiko Aoki, et al.The Prostate|January 1, 1992
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinomaJ L Mohler, L G Gomella, E D Crawford, et al.The Prostate|May 27, 2004
Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft modelWendy J Huss, Danny R Gray, Eric S Werdin, et al.The Prostate|May 27, 2004
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cellsYeong-Shiau Pu, Tzyh-Chyuan Hour, Shuang-En Chuang, et al.The Prostate|May 27, 2004
Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activityFelice Arcuri, Stefania Papa, Antonietta Carducci, et al.Pageof 593